印度制藥業(yè)分析(英文).docx

印度制藥業(yè)分析(英文).docx

ID:25147715

大?。?.30 MB

頁數(shù):38頁

時間:2018-11-18

印度制藥業(yè)分析(英文).docx_第1頁
印度制藥業(yè)分析(英文).docx_第2頁
印度制藥業(yè)分析(英文).docx_第3頁
印度制藥業(yè)分析(英文).docx_第4頁
印度制藥業(yè)分析(英文).docx_第5頁
資源描述:

《印度制藥業(yè)分析(英文).docx》由會員上傳分享,免費在線閱讀,更多相關(guān)內(nèi)容在行業(yè)資料-天天文庫。

1、PHARMACEUTICALSForupdatedinformation,pleasevisitwww.ibef.orgOctober2018TableofContentExecutiveSummary3AdvantageIndia4MarketOverview6RecenttrendsandStrategies16GrowthDrivers20Opportunities30UsefulInformation…32EXECUTIVESUMMARYLeadingpharmaproducer§Indianphar

2、maceuticalindustrysuppliesover50percentofglobaldemandforvariousvaccines,40percentofgenericdemandintheUSand25percentofallmedicineinUK1.Oneofthehighestexports§Indiaaccountsfor20percentofglobalexportsingenerics.India’spharmaceuticalexportsstoodatUS$17.27billio

3、nin2017-18andareexpectedtoreachUS$20billionby2020.In2018-19theseexportsareexpectedtocrossUS$19billion.Amongfastestgrowinindustries§Thecountry’spharmaceuticalindustryisexpectedtoexpandataCAGRof22.4percentover2015–20toreachUS$55billion2.Indiaisthesecondlarges

4、tcontributorofglobalbiotechandpharmaceuticalworkforce.ThepharmaceuticalsectorwasvaluedatUS$33billionin2017.gRapidlygrowinghealthcaresector§Indianhealthcaresector,oneofthefastestgrowingsectors,isexpectedtocrossUS$372billionby2022.Highpotentialgenericsmarket§

5、ThedomesticgenericsmarketisexpectedtoreachUS$27.9billionby2020.India’sgenericsmarkethasimmensepotentialforgrowth.Indianpharmaceuticalcompaniesreceivedrecord300genericdrugapprovalsinUSAduring2017wherethegenericmarketisexpectedtoreachUS$88billionby2021.Robust

6、growthinBiotecindustry§By2024-25,India’sbiotechindustryisestimatedtoincreasetoUS$100billion.hNotes:InformationasperlatestavailabledataSource:1FICCI-Trends&OpportunitiesforIndianPharma2018,Pharmexcil,2TechSciResearch,AssochamandRNCOS3PharmaceuticalsForupdate

7、dinformation,pleasevisitwww.ibef.orgPharmaceuticalsADVANTAGEINDIAADVANTAGEINDIA5PharmaceuticalsForupdatedinformation,pleasevisitwww.ibef.org§LowcostofproductionandR&DboostsefficiencyofIndianpharmacompanies,leadingtocompetitiveexports.Indianpharmaexportsreac

8、hedUS$17.27billioninFY18.§India’scostofproductionisapproximately33percentlowerthanthatoftheUS.§India’sabilitytomanufacturehighquality,lowpricedmedicines,presentsahugebusinessopportunityforthedomesticin

當前文檔最多預覽五頁,下載文檔查看全文

此文檔下載收益歸作者所有

當前文檔最多預覽五頁,下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學公式或PPT動畫的文件,查看預覽時可能會顯示錯亂或異常,文件下載后無此問題,請放心下載。
2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫負責整理代發(fā)布。如果您對本文檔版權(quán)有爭議請及時聯(lián)系客服。
3. 下載前請仔細閱讀文檔內(nèi)容,確認文檔內(nèi)容符合您的需求后進行下載,若出現(xiàn)內(nèi)容與標題不符可向本站投訴處理。
4. 下載文檔時可能由于網(wǎng)絡(luò)波動等原因無法下載或下載錯誤,付費完成后未能成功下載的用戶請聯(lián)系客服處理。